What STAT readers think about the FDA and patient advocacy


STAT is now publishing selected Letters to the Editor in response to First Opinion essays to encourage discussion on difficult issues. The letters include one from a former FDA associate commissioner who strongly disagrees with an article casting doubt on the agency. A patient advocate in Canada provides a different perspective on advocating for treatment access. Another letter discusses the importance of utility and the patient’s perspective in medical testing. Lastly, a reader supports a recent essay criticizing Medicare’s annual wellness visits for being insulting and degrading. The publication is encouraging participation in discussions by submitting Letters to the Editor.

Source link

error: Content is protected !!